invasive · single-unit · clinical-trial
Connexus Brain-Computer Interface
By Paradromics
Identity
- Manufacturer
- Paradromics
- Model number
- —
- Codename
- —
- Aliases
- Connexus Direct Data Interface, Connexus BCI
- Generation
- —
- Country of origin
- US
- Released
- Announced
- —
- Discontinued
- —
- Status
- clinical-trial
Classification
- Invasiveness
- invasive
- Modalities
- single-unit, multi-unit
- Primary modality
- single-unit
- Direction
- read
- Categories
- medical-implant, communication-aac, prosthetic-control
- Form factor
- intracortical-implant, cranial-implant
- Use cases
- speech restoration via decoded text / synthesised speech, computer / device control for severe motor impairment
- Target users
- patient-als, patient-spinal-cord-injury, patient-stroke, patient-paralysis, patient-locked-in
Electrodes
- Total channels
- 421
- Recording channels
- 421
- Reference channels
- —
- Electrode type
- penetrating-shank
- Material
- platinum-iridium
- 10-20 positions
- —
- Requires gel
- No
- Requires saline
- No
- Prep time
- —
- Reusable
- No
- Disposable
- No
Signal acquisition
- Sampling rate
- —
- ADC resolution
- —
- Notch filters
- —
- Onboard artifact rejection
- —
Stimulation
- Capable
- No
Connectivity
- Protocols
- transcranial-inductive
- Bluetooth
- —
- Bluetooth profiles
- —
- Concurrent mode
- —
- Encryption (transit)
- —
- Pairing methods
- —
- Cloud sync
- —
- Offline recording
- —
Power
- Sources
- transcutaneous-inductive
- Battery life (active)
- —
- Charging port
- —
- Charging time
- —
- Battery replaceable
- —
- Notes
- Wireless transcutaneous power; no transcutaneous connector.
Physical
- Weight
- —
- Dimensions
- —
- Materials
- titanium-alloy, platinum-iridium
- Sizes
- —
- Head circumference
- —
- Operating temp
- —
Compute
- Has onboard computer
- —
- Operating systems
- —
- Primary OS
- —
- Edge ML accelerator
- —
- Root access
- —
- App sandbox
- —
- 3rd-party apps allowed
- —
- Notes
- Hermetic module contains a custom acquisition ASIC with on-implant signal conditioning and telemetry. Detailed compute specs have not been publicly disclosed.
Software & data
- Mobile app
- —
- Cloud platform
- —
- Offline mode
- —
- Subscription required
- —
- Raw data access
- No
- Export formats
- —
- LSL support
- —
- Data ownership
- manufacturer
- Apps
- —
SDK & developer access
- Has SDK
- No
- Open source
- No
- Languages
- —
- Web Bluetooth
- —
- Raw sample access
- —
- BCI paradigms
- decoded-speech, imagined-speech, cursor-control, click-decoder
- 3rd-party integrations
- —
- Docs
- —
Capabilities
- Attention / focus
- —
- Meditation / calm
- —
- Neurofeedback
- —
- Meditation coaching
- —
- Sleep tracking
- —
Security
- Authentication factors
- —
- Per-user profiles
- —
- Requires account
- —
- Claiming methods
- —
- Ownership model
- —
- Activation lock
- —
- Remote lock
- —
- Remote wipe
- —
- Find my device
- —
- Notes
- —
Firmware & updates
- OTA supported
- —
- OTA transports
- —
- Update mechanism
- —
- Update channels
- —
- Rollback supported
- —
- Signed updates
- —
- Forced updates
- —
- User deferrable
- —
- Requires app companion
- —
- Average update frequency
- —
- Notes
- —
Regulatory & clinical
- FDA status
- investigational-device-exemption
- CE mark
- —
- Certifications
- —
- Prescription required
- Yes
- Pediatric approved
- —
Pricing & availability
- MSRP
- —
- Current price
- —
- Subscription
- —
- Warranty
- —
- Return policy (days)
- —
- Where to buy
- —
Media & links
- Official site
- paradromics.com
- Product page
- paradromics.com
Editor’s take
In favor
- Modular: scales to 1,600+ channels by adding more sub-dime implants
- FDA Breakthrough Device + IDE; first US IDE for fully-implantable speech BCI
- Targets the specific high-value application of speech restoration
Against
- Pre-clinical / first-in-human stage — limited published human data so far
- Most internal hardware specs are proprietary / unverified
- Multi-module implantation increases surgical exposure relative to a single device
Sources & provenance
- Paradromics — official site
- Paradromics — Connexus product page
- Paradromics — Connect-One IDE announcement (Nov 2025)
- STAT — FDA approves Paradromics speech-restoration trial
Last reviewed